Skip to main content

Main menu

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine
  • SNMMI
    • JNM
    • JNMT
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • JNM Supplement
    • SNMMI Annual Meeting Abstracts
    • Continuing Education
    • JNM Podcasts
  • Subscriptions
    • Subscribers
    • Institutional and Non-member
    • Rates
    • Journal Claims
    • Corporate & Special Sales
  • Authors
    • Submit to JNM
    • Information for Authors
    • Assignment of Copyright
    • AQARA requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • View or Listen to JNM Podcast
  • Visit JNM on Facebook
  • Join JNM on LinkedIn
  • Follow JNM on Twitter
  • Subscribe to our RSS feeds
Meeting ReportOncology: Basic, Translational & Therapy: Basic Science

First experience with BAY 94-9392, a novel F-18 L-glutamate derivative, for PET/CT imaging in patients with non-small cell lung and breast cancer

Sora Baek, Chang-Min Choi, Sei hyun Ahn, Jong Won Lee, Jin-Sook Ryu, Seung Jun Oh, Claudia Bacher-Stier, Lüder Fels, Ludger Dinkelborg and Dae Hyuk Moon
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 195;
Sora Baek
1Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Chang-Min Choi
2Pulmonology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Sei hyun Ahn
3Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jong Won Lee
3Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jin-Sook Ryu
1Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Seung Jun Oh
1Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudia Bacher-Stier
4Bayer Schering Pharma AG, Global Drug Discovery, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Lüder Fels
4Bayer Schering Pharma AG, Global Drug Discovery, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Ludger Dinkelborg
4Bayer Schering Pharma AG, Global Drug Discovery, Berlin, Germany
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Dae Hyuk Moon
1Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Article Information

vol. 52 no. supplement 1 195

Published By 
Society of Nuclear Medicine
Print ISSN 
0161-5505
Online ISSN 
2159-662X
History 
  • Published online November 4, 2014.

Copyright & Usage 
© 2011

Author Information

  1. Sora Baek1,
  2. Chang-Min Choi2,
  3. Sei hyun Ahn3,
  4. Jong Won Lee3,
  5. Jin-Sook Ryu1,
  6. Seung Jun Oh1,
  7. Claudia Bacher-Stier4,
  8. Lüder Fels4,
  9. Ludger Dinkelborg4 and
  10. Dae Hyuk Moon1
  1. 1Nuclear Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
  2. 2Pulmonology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
  3. 3Surgery, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea
  4. 4Bayer Schering Pharma AG, Global Drug Discovery, Berlin, Germany

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: January 2015 to April 2025

AbstractFullPdf
Jan 2015200
Apr 2015500
Jun 2015500
Jul 2015300
Sep 2015500
Nov 2015100
Apr 2016100
Aug 2016100
Sep 2016300
Oct 2016300
Nov 2016100
Dec 2016100
Jan 2017200
Feb 2017300
Apr 2017400
May 2017500
Jul 2017100
Sep 2017200
Oct 2017200
Nov 2017100
Jan 2018100
Apr 2018100
May 2018300
Jun 2018200
Aug 2018100
Sep 2018500
Oct 2018100
Dec 2018100
Jul 2019200
Oct 2019100
Nov 2019400
Dec 2019100
Jan 2020200
Feb 2020600
Mar 20201400
Apr 2020900
May 2020300
Jun 2020300
Jul 2020600
Aug 20202000
Sep 20203500
Oct 20202200
Nov 20202100
Dec 20201400
Jan 2021700
Feb 20211500
Mar 20211200
Apr 20211300
May 20211900
Jun 20211500
Jul 20212600
Aug 20215000
Sep 20212000
Oct 20211500
Nov 20218000
Dec 20216300
Jan 20228200
Feb 20222000
Mar 20226200
Apr 20223100
May 20223300
Jun 2022400
Jul 2022500
Aug 2022500
Sep 2022300
Oct 2022600
Nov 20221700
Dec 2022200
Jan 2023300
Feb 2023300
Mar 2023600
Apr 2023900
May 2023800
Jun 2023800
Jul 2023700
Aug 20231500
Sep 2023900
Oct 20231800
Nov 2023300
Dec 2023600
Jan 2024600
Feb 2024800
Mar 2024500
Apr 2024500
May 20241100
Jun 2024800
Jul 2024200
Aug 2024300
Sep 2024400
Oct 2024500
Nov 2024600
Dec 2024500
Jan 2025100
Mar 2025100
Apr 2025200
Back to top

In this issue

Journal of Nuclear Medicine
Vol. 52, Issue supplement 1
May 2011
  • Table of Contents
  • Index by author
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
First experience with BAY 94-9392, a novel F-18 L-glutamate derivative, for PET/CT imaging in patients with non-small cell lung and breast cancer
(Your Name) has sent you a message from Journal of Nuclear Medicine
(Your Name) thought you would like to see the Journal of Nuclear Medicine web site.
Citation Tools
First experience with BAY 94-9392, a novel F-18 L-glutamate derivative, for PET/CT imaging in patients with non-small cell lung and breast cancer
Sora Baek, Chang-Min Choi, Sei hyun Ahn, Jong Won Lee, Jin-Sook Ryu, Seung Jun Oh, Claudia Bacher-Stier, Lüder Fels, Ludger Dinkelborg, Dae Hyuk Moon
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 195;

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
First experience with BAY 94-9392, a novel F-18 L-glutamate derivative, for PET/CT imaging in patients with non-small cell lung and breast cancer
Sora Baek, Chang-Min Choi, Sei hyun Ahn, Jong Won Lee, Jin-Sook Ryu, Seung Jun Oh, Claudia Bacher-Stier, Lüder Fels, Ludger Dinkelborg, Dae Hyuk Moon
Journal of Nuclear Medicine May 2011, 52 (supplement 1) 195;
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
  • Info & Metrics

Related Articles

  • No related articles found.
  • Google Scholar

Cited By...

  • No citing articles found.
  • Google Scholar

More in this TOC Section

Oncology: Basic, Translational & Therapy: Basic Science

  • Modification of chemical structure to improve biodistribution of a radiolabeled sigma ligand for tumor-imaging
  • A Cy5** labelled anti-EGFR affibody selectively targets EGFR in mouse xenograft model
  • Human liver regeneration. From experimental research to clinical application
Show more Oncology: Basic, Translational & Therapy: Basic Science

Basic Science II (Oncology): Peptides/Small Molecules

  • Preclinical evaluation of TSPO ligand [18F]DPA-714 for PET imaging of glioma
  • GPER-targeted 99mTc-labeled non-steroidal analogues for breast and endometrial cancer imaging demonstrate in vivo estrogen binding of GPER
  • In vivo evaluation of [F-18]-labeled 3,5-bis(2-fluorobenzylidene)-4-piperidone as an imageable antiproliferative agent
Show more Basic Science II (Oncology): Peptides/Small Molecules

Similar Articles

SNMMI

© 2025 SNMMI

Powered by HighWire